HomeOwner SearchCategory Search
Visit USCOThe Essential Guide to Prescription Drugs, Update on rivaroxaban, Xarelto lowers MACE and reversal is a reality
Text Registration
Copyright Title
The Essential Guide to Prescription Drugs, Update on rivaroxaban, Xarelto lowers MACE and reversal is a reality
Status
Published
on 8 Nov 2018
Year of Creation
2018
Copyright Claimant
The Medicine Information Institute
Registration Number
TX0008667449
on 8 Nov 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008667449) dated 8 Nov 2018, pertains to an electronic file (eService) titled "The Essential Guide to Prescription Drugs, Update on rivaroxaban, Xarelto lowers MACE and reversal is a reality" created in 2018. The copyright holder is The Medicine Information Institute, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to The Medicine Information Institute.
Application Details
Registration Number
TX0008667449
Registration Date
11/8/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Medicine Information Institute
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISBN
978-1-891678-70-7
Preexisting Material
previously-published material
Notes
Rights Note: Dr. James Joseph Rybacki, 3338 Cappio Dreive, Melbourne, FL, 32940, United States, (410) 310-2578, medconsult@aol.com
Local Copyright Note: C.O. correspondence
Material Matter Claimed Note: new and revised material including text, photograph(s), artwork
Statements
Application Title Statement: The Essential Guide to Prescription Drugs, Update on rivaroxaban, Xarelto lowers MACE and reversal is a reality
Author Statement: The Medicine Information Institute 1954 employer for hire Domicile: United States Authorship: new and revised material including text, photograph(s), artwork
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.